Agenus
AGEN • NASDAQ
Agenus is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Garo H. Armen, with a market cap of $130.2M.
CEOGaro H. Armen
Next Earnings
Upcoming earnings announcement for Agenus
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.73
Revenue Estimate
$88.3M
Earnings History
Past 12 earnings reports for Agenus
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$0.37Est: -$1.28 | +71.1% | $34.2MEst: $28.5M | +20.0% |  10-K |
| Nov 10, 2025 | Q3 2025 | $1.94Est: $2.24 | -13.4% | $30.2MEst: $91.3M | -66.9% | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$1.00Est: $0.50 | -300.0% | $25.7MEst: $39.8M | -35.5% | 10-Q |
| May 12, 2025 | Q1 2025 | -$1.03Est: -$1.61 | +36.0% | $24.1MEst: $21.0M | +14.7% | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$2.04Est: -$2.54 | +19.7% | $26.8MEst: $30.1M | -10.8% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$3.08Est: -$2.33 | -32.2% | $25.1MEst: $33.5M | -25.0% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$2.52Est: -$1.44 | -75.0% | $23.5MEst: $61.5M | -61.8% | 10-Q |
| May 7, 2024 | Q1 2024 | -$3.04Est: -$2.83 | -7.4% | $28.0MEst: $39.3M | -28.7% | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$2.60Est: -$1.00 | -160.0% | $83.8MEst: $47.1M | +78.1% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$3.20Est: -$3.80 | +15.8% | $24.3MEst: $24.3M | -0.1% | — |
| Aug 8, 2023 | Q2 2023 | -$4.00Est: -$4.00 | 0.0% | $25.3MEst: $24.1M | +4.9% | 10-Q |
| May 9, 2023 | Q1 2023 | -$4.40Est: -$4.20 | -4.8% | $22.9MEst: $23.0M | -0.3% | — |